Состояние сердечно-сосудистой системы у больных злокачественными лимфомами в различные сроки после лучевой и химиотерапии
Диссертация
Основные положения диссертационной работы доложены и обсуждены на' заседании Науч. практ. конф. «Современные методы лучевой диагностики заболеваний ССС», Томск 17−18 сент., 2002; Науч. конф. «Современные технологии в клинической медицине», Санкт-Петербург, ЦНИРРИ* окт., 2003; заседании Эхо Клуба Санкт-Петербурга 16.06.2004. По теме диссертации опубликовано 9 научных работ, в их числе статья… Читать ещё >
Список литературы
- Алиев Б.М., Васыгова Н. Ф., Е.М. Иванова и др. Пяти-, десятилетние результаты лечения и отдаленные последствия лучевой терапии по радикальной программе больных лимфогранулематозом I-III стадий // Вопр. Онкологии. 1984. — № 6. — С.41−47.
- Антипенко Е.Н. Остаточные явления острой лучевой болезни. М.: Мед-гиз, 1963.-95с.
- Бардычев М.С. Лучевые повреждения // В кн.: Лучевая терапия злокачественных образований. / Под. ред. Е. С. Киселевой. М.: Медицина. — 1996. — С.437−459.
- Бухарова И.В., Мухаметшина Г. З., Гимранов A.M. Постлучевой перикардит у больных ЛГМ. // Паллиативная медицина и реабилитация. 2001.1. С.12−18
- Байсоголов Г. Д. Клинические исследования по диагностике и лечениюлимфогранулематоза (1967−1986 г. г.) // Мед. Радиология. 1987. — № 9. -С. 67−73.
- Балашов А.Т., Мясников А. А. Функциональное состояние сердечно, сосудистой системы в отдаленные сроки после комплексной терапии убольных ЛГМ // Терапевтический архив. 1996. — № 12. — С. 12−14.
- Боровиков В.П. Программа STSTISTICA для студентов и инженеров. М.:1.j КомпьютерПресс. 2001. — 301 с.
- Василенко И.Я. Радиационные поражения продуктами ядерного деления. / Здравоохранение Белоруссии.- 1986. № 12. — С. 68.
- Воробьев Е.И. Изменение сердечно-сосудистой системы при воздействии ионизирующей-радиации (экспериментальное исследование). Автореф. дисс. д-ра мед. наук.- СПб -1992.- 22 с.
- Гершанович М.JI. Кардиоксан как протектор кардиотоксичности антрациклинов (По материалам сателлитного симпозиума фирмы CSC Ltd.) // Вопр. онкол. 1996. — № 6 — с. 98−99.
- Гершанович M. J1. Осложнения при химио- и гормонотерапии злокачественных опухолей. М.: Медицина. — 1982. — 224 с.
- Гранов A.M., Винокуров B.JI. Лучевая терапия в онкогинекологии и онко-урологии./ Под ред. чл.-кор. РАМН проф. А. М. Гранова, проф. В. Л. Винокурова. СПб: ООО «ФОЛИАНТ». — 2002. — 352 с.
- Григорьев Ю.Г. Отдаленные последствия биологического действия электромагнитных полей.// Рад. биол. Радиоэк.- 2000. № 2. — С. 217
- Демена Е.А. Современные подходы к лечению лимфогранулематоза. // Современная онкология. 2002. — № 1.— с. 49−53.
- Жданов B.C. Роль гиперплазии интимы артерий в атерогенезе у человка // Архив патологии. 1998. — № 6. — С. 8−13.
- Ильин Н.В. Лимфогранулематоз (Лимфома Ходжкина). Неходжкинские лимфомы, — СПб. 2003. — 80 с.
- Калинкина Н: В. Повреждения сердца антрациклинами: частота и факторы риска. // Украинский медицинский журнал. 2000 г. — № 2 (16)
- Капелько В.И. Внеклеточный матрикс миокарда и его изменения при заболеваниях сердца. // Кардиология. 2000 г. — № 9 — с.78−89
- Колдаев В.М. Фармакологическая коррекция острых эффектов от микроволновой радиации в эксперименте./ Научные док. Высш. Шк. Науки. -2002. -№ 1.-С. 20−26
- Красильникова JI.A. Ультразвуковая диагностика ангиопатий при противоопухолевой терапии.// Автореф. дисс. канд. мед. наук.- СПб -1995.- 18 с.
- Мясников А.А., Балашов А. Т. Поздние осложнения комплексной терапии ЛГМ. // Клиническая медицина. — 1997. — № 3. — с. 21−23.
- Москалев Ю.И., Стрельцова В. Н. Отдаленные последствия воздействия ионизирующих излучений на животных. / В кн.: Основы радиационной биологии. М., Наука. — 1964. — С.238.
- Нагорнев В.А., Яковлева О. А., Мальцева С. В. Атерогенез как отражение развития иммунного воспаления в сосудистой стенке./ ВестРАМН. 2000. — № 10.-С.: 45−50.
- Новые подходы к скринингу, диагностике и лечению новообразований яичников". Новгород, 2001. Материалы конференции. Глава 5. «Осложнения лучевой терапии и первичные опухоли».
- Новиков В.И., Шлойдо Е. А. Оценка гемодинамического влияния нарушений диастолической функции.// Ультразвуковая и функциональная диагностика. 2001. -№ 3. — С. 49−53.
- Преображенский Д.В., Сидоренко Б. А., Шатунова И. М. и соавт. Застойная хроническая сердечная недостаточность с нормальной функцией левого желудочка. // Кардиология. 2001. — № 1. — С.85−9Г.
- Проблемы радиационной геронтологии. Под ред. д.б.н. проф. С. Н. Александрова. //Современные вопросы радиобиологии.// Москва. Атомиздат.. 1978.-78 с.
- Радиационное поражение организма. Под ред. д.б.н. И. Г. Акоева. // Современные проблемы-ардиобиологии // Москва. Атомиздат. 1976. -114 с.
- Ревес JL, Литбранд Б., Бидандер Дж., Скотт О. // Жизнеспособность клеток, облученных в малых дозах: теоретические и клинические аспекты./ Под ред. Т. Альпер: Пер. с англ. М., 1980. — С. 128−136.
- Струтынский А.В. Эхокардиограмма: анализ и интерпрета-ция:Учебн.пособ. М.: МЕДпресс-информ. — 2003. — 208 с.
- Скворцова О.Ю., Сотников В. М. Холтеровское мониторирование ЭКГ у больных лимфомой Ходжкина в процессе лучевой терапии. // Всероссийский научный форум «Радиология 2005». М. — 2005. — С.268.
- Химиотерапия. Справочник./Под ред. Переводчиковой Н. И. // Медицина. -М.- 1986.-204 с.
- Холин А.В. Осложнения лучевого и комбинированного лечения лимфогранулематоза. //Мед. радиология.-1984.-№ 9-С. 66−74.41 .Шиллер Н., Осипов М. А. Клиническая эхокардиография. М. — 1993. -314 с.
- Шубик Ю.В. Суточное мониторирование ЭКГ при нарушениях ритма ипроводимости сердца. С-Пб. — 2001. — 216 с.
- Шхвацабая J1.B., Алиев Б. М., Чебан О. И., Неклюдова В. И., Васыгова
- Н.Ф. Постлучевые перикардиты у больных лимфогранулематозом. Кардиология. 1986 г. — № 12. — с.28−32.
- Тихоненко В.М. Формирование клинического заключения по даннымхолтеровского мониторирования. СПб. — :Инкарт. — 2000. — 36 с.
- Ярмоненко С.П., Вайнсон А. А. Радиобиология человека и животных. -М'.: Высшая школа 2004. — 549 с.
- Adams M.J., Hardenbergh Р.Н., Constine L.S., Lipshultz S.E. Radiation-associated cardiovascular disease.// Crit Rev Oncol Hematol. -2003. V.45(l) -P.55−75.
- Agarwala S., Kumar R., Bhamagar V. et al. High incidence of adnamycin car-diotoxicity in children even at low cumulative doses role of radionuclide cardiac angiography. // J Pediatr Surg 2000. — V.35. — P. l786−1789.
- Aisenberg A.G. Problems in Hodgkin’s Disease Management.// Blood// V.93 -N. 3−1999.-P.761−779.
- Alexander J., Daimak N., Berger H.J. et al. Serial assessment of doxo-rubicin cardiotoxicity with quantitative radionuclide angiocardiography. // N. Engi. J. Med. 1979. — V.300. — P.278−283.
- Ali M.K., Kahlil K.G., Fuller L.M. et al. Radiation-related myocardial injury. Management of two cases. // Cancer 1976. -V. 38(5). — P. 1941−1946.
- Allavena С., Conroy Т., Aletti P., Bey P., Lederlin P. Late cardiopulmonary toxicity after treatment for Hodgkin’s disease. // Br J Cancer 1992. -V.65(6). -P.908−12.
- Allen A. The cardiotoxicity of chemotherapeutic drugs. // Semm. Oncol. -1992,-V 19.-P. 529−542.
- Andresen H., Kaag N., Meinhardt A., Potratz J. Radiation-induced cardiac disease. // Z Kardiol. 2003. — V.92(l I). — P.957−61.
- Annest L.S., Anderson R.P., Li W., Hafermann M.D. Coronary arteiy disease following mediastinal radiation therapy. //J Thorac Cardiovasc Surg. 1983. -V.85(2). — P.257−63.
- Applefeld M.M., Slawson R.G., Spicer K.M., Singleton R.T., Wesley M.N., Wiernik PH. Long-term cardiovascular evaluation of patients with Hodgkin’s disease treated by thoracic mantle radiation therapy.// Cancer Treat Rep 1982. -V.66(4). — P.1003−13.
- Apter S., Shemesh J., Raanani P. et al. Cardiovascular calcifications after radiation therapy for Hodgkin lymphoma: computed tomography detection and clinical correlation. //Coron Artery Dis. 2006. — V. 17(2). — P. 145−51.
- Arom K.V., Bishop V.S., Grover F.L., Trinkle J.K. Effect of therapeutic-dose irradiation on left ventricular function in conscious dogs. // Ann.Jborac. Surg. -1979. V.28(2). — P.166−175.
- Arsenian M.A. Cardiovascular sequelae of therapeutic thoracic radiation.// Prog Cardiovasc Dis. 1991. — V.33(5): — P.299−311.
- Basavaraju S.R., Easterly C.E. Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications // Med Phys. 2002. — V.29(10). — P.2391−403.
- Basser R.L., Green M.D. Strategies for prevention of anthracycline cardiotoxic-ity. // Cancer Treat Rev 1993. — V. 19. — P.57−77.
- Baylac-Domengetroy F., Gallimard J.F., Elbaz-Rostykus C., Coisne D., Allal J., Barraine R. Rhythm complications of radiotherapy. // Apropos of a case Ann Cardiol Angeiol (Paris) 1989.- V.38(4). — P.219−23.
- Benoff L.J., Schweitzer P. Radiation therapy-induced cardiac injury. Am Heart J. 1996.-V.131(6).-P.1235−6.
- Biran S. Corticosteroids in radiation-induced1 pericarditis. // Chest 1978. -V.74(l). — P.96−8.
- Boivin J.F., Hutchison G. B, Lubin J.H., Mauch P. Coronary artery disease mortality in patients treated for Hodgkin’s disease. // Cancer — 1992. -V.l-69(5). P.1241−7.
- Brice P., Tredaniel J., Monsuez J.J., Marolleau J.P., Ferme C., Hennequin1 G.-,' Frija J., Gisselbrecht C., Boiron M. Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin’s disease. // '
- Ann Oncol-1991. -V.2.-P.73−6.
- Brosius F.C.3rd, Waller B.F., Roberts W.C. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart.//Am J Med 1981.-V.70(3).-P.519−30/
- Byhardt R., Brace K., Ruckdeschel J., Chang P., Martin R., Wiernik P. Dose and treatment factors in radiation-related pericardial effusion associated with the mantle technique for Hodgkin’s disease. //Cancer 1975. — V.35(3).1. P.795−802.
- Cardinale D., Sandri M.T., Colombo A. et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy.// Circulation. 2004. V. 109. — P.2749−2754.
- Carlson R.G., Mayfield W.R., Normann S., Alexander J.A. Radiation-associated valvular disease. //Chest 1991. — V.99(3). — P.538−45.
- Carrio I., Estorch M., Bema L. et al. Assessment of anthracychne-induced myocardial damage by quantitative indium 111 myosin-specific monoclonal antibody studies. //Eur J Nucl Med 1991. — V. 18. — P.806−812.
- Carrio I., Estorch M., Bema L. et al. Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity. //J Nucl Med -1995 V.36. — P.2044−2049.
- Carrio I., Lopez-Pousa A., Estorch M. et al. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111 -antimyosin monoclonal' antibody studies.// J Nucl Med 1993.- V.34. — P. 1503−1507.
- Chlebowski R.T. Adriamycin (doxorubicin) cardiotoxity: a review. // West. J. Med. 1979, — V.131. — P.364−368.
- Chou K.M., Krapcho A.P., Horn D., Hacker M. Characterization of anthra-cenediones and their photoaffmity analogs. // Biochem biochem Pharmacol — 2002. V. 15−63(6). — P. 1143−7.
- Cocchieri M., Ramoni N., Severini D. Cardiotoxicity induced by radiotherapy. // Minerva Cardioangiol 1993. — V.41 (4). — P.119−22.
- Constine L.S., Schwartz R.G., Savage D.E. et al. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin’s disease. // Int J Radiat Oncol Biol Phys 1997. — V.39. — P.897−906.
- Corn B.W., Trock B.J., Goodman R.L. Irradiation-related ischemic heart disease. // J Clin Oncol 1990. — V.8. — P.741−750.
- Cosset J.M., Henry-Amar M., Pellae-Cosset В., Carde P., Girinski Т., Tubiana M, Hayat M. Pericarditis and myocardial infartion after Hodgkin’s disease therapy. // Int j Radiat Oncol Biol Phys 1991. — V.21(2). — P.447−9.
- Cottin Y., L’huillier I., Casasnovas O., Geoffroy C., Caillot D., Zeller M, So-lary E., Guy H., Wolf J.E. Dobutamine stress echocardiography identifies an-thracycline cardiotoxicity. //Eur J Echocardiogr-2000. V. l (3). -P.180−3.
- Delbruck HG. Necessary diagnostic and therapeutic measures in the rehabilitation of «cured» patients with Hodgkin’s disease. // Rehabilitation (Stuttg) — 1985. V.24(4). — P.187−91.
- Di Matteo J., Vacheron A., Heulin A., et al. // Cardiac complications of thoracic radiotherapy. 1978. — V.71(4). — P.447−52.
- Donaldson S.S., Hancock S.L., Hopp R.T. The Janeway lecture. Hodgkin’s disease finding the balance between cure and late effects // Cancer J Sci Am -1999 — V.5(6). — P.325−33.
- Dreicer R., Karwal M.W., Midence G. et al. The role of radionuclide angiocar-diographyin the treatment of patients receiving doxorubicin-based chemotherapy: a reassessment. // Am. J. Clin. Oncol. 1997. — V.20. — P. 132−137.
- Ebagosti A., Gueunoun M., Favre R., et al. Atrioventricular block, a complication of radiotherapy of the mediastinum. // Arch Mai Coeur Vaiss 1989. -V.82(6) — P.935−9.
- Estorch M., Carrio I., Bema L. et al. Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. // J Nucl Med -1990. V.31. — P. 1965−1969.
- Fadillioglu E., Erdogan H., Sogut S., Kuku I. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. 7/ J Appl Toxicol. — 2003.- V.23(l). P.71−4.
- Fajardo L.F., Eltringham J.R., Steward4 J.R. Combined cardiotoxicity of adria-mycin and x-radiation. // Lab Invest 1976/ - V.34(l). -P.86−96.
- Fassio Т., Canobbio L., Gasparini G., Villani F. Paroxysmal supraventricular tachycardia during treatment with cisplatin and etoposide combination. // Oncology- 1986.- V.43(4).-P.219−20.
- Galderisi M., Marra F., Esposito R., ey al. Cancer therapy and cardiotoxicity :. the need of serial Doppler echocardiography. //Cardiovasc Ultrasound^- 2007. -V.25.-P.5.
- Germano G., Kiat H., Kavanagh P.B. et al. Automatic quantification of ejection fraction from gated myocardial perfusion. // SPECT J. Nucl. Med. 1995. -V.36. — P.2138−2147.
- Glanzmann C., HugueninP., Lutolf U. Mi, et al. Cardiac lesions after mediastinal irradiation for Hodgkin’s disease. //Radiother Oncol -1994/ V:30(l).s1. P.43−54.
- Glanzmann C., Kaufmann P., Jenm R. et al. Cardiac risk after mediastinal irradiation for Hodgkin’s disease. //Radiother Oncol 1998. — V.46. — P.51−62.
- Grollier G., Commeau P., Potier J.C. Radiation-induced'cardiopathies// Presse Med. 1986 — V.26−15(17). — P.797−800.
- Guldner L., Haddy N., Pein F. et al. Radiation dose and long term risk. of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer. //Radiother Oncol. 2006. — V.81(l). — P.47−56.
- Gustavsson A., Bendahl P-0., Cwikiel M. et al. No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer. // Int. J. Radiat. Oncol. Biol. Phys. 1999. — № 43. -P.: 745−754
- Gustavsson A, Eskilsson J- Landberg T, Svahn-Tapper G, White T, Wollmer P, Akerman M: Late cardiac effects after mantle radiotherapy in patients with Hodgkin’s disease.//Ann Oncol. 1990. — V. l (5). — P.355−63.
- Gyenes G., Fomander Т., Carlens P. et al. Detection of radiation induced myocardial damage by technetium-99m sestamibi scintigraphy. // Eur. J. Nucl. Med. 1997. — V.24. — P.286−292.
- Gyenes G., Fomander Т., Carlens P. et al. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy a prospective study. //Int J Radiat Oncol Biol Phys. 1996. — V.36. — P.899−905.
- Haas J.M. Symptomatic constrictive pericarditis developing 45 years after radiation therapy to the mediastinum. A review of radiation pericarditis. //Am Heart J. 1969: — V.77(l). — P.89−95.
- Hancock S.L., Donaldson S.S., Hoppe R.T. Cardiac disease following treatment of Hodgkin’s disease in children and adolescents. //J Clin Oncol. 1993.1. V. l 1(7). P. 1199−203.
- Hancock S.L., Hoppe R.T. Late-term complications, of treatment and causes of mortality after Hodgkin’s disease. //Semin Radial Oncol/ 1996. — V.6: -P.225−242.
- Hancock S.L., Tucker M.A., Hoppe R.T. Factors affecting late mortality fromeiheart didease after treatment of Hodgkin’s didease. //JAMA. 1993. — V.270. -P.1949−1955.
- Hardenbergh P.H., Munley M.T., Bentel G.C. et al. Cardiac perfusior changes in patients treated for breast cancer with radiation therapy and doxorubicin preliminary results. //Int J Radiat Oncol Biol Phys. 2001. — V.49. — P. 1023−1028.
- Hashimoto I., Ichida F., Miura M. et al. Automatic border detection identifies subclinical anthracycline cardiotoxicity in children with malignancy. // Circulation. 1999. — V.99. — P.2367−2370.
- Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. //J Am Coll Cardiol. -2003. V.20−42(4). — P.743−9.
- Heidenreich P.A., Hancock S.L., Vagelos R.H., Lee B.K., Schnittger I. Diastolic dysfunction after mediastinal irradiation. //Am Heart J. 2005.1. V. 150(5). P.977−82.
- Henry-Amar M., Gisselbrecht C. Late treatment related complications of Hodgkin’s disease. // Rev Prat 1998. — V.15−48(10). — P. 1092−7.
- Henry-Amar M., Joly F. Late complications after Hodgkin’s disease. //Ann Oncol. 1996. — V.7−4. — P. 115−26.
- Hicks G.L. Jr. Coronary artery operation in radiation-associated atherosclerosis long-term follow-up. // Ann Thorac Surg. 1992. — V.53(4). — P.670−4.
- Hirose Y., Ishida Y., Hayashida K., et al. A case of radiation-induced1 chronic constrictive pericarditis developing 16 years after irradiation. // Kaku Igaku. -1993. V.30(9). — P.1091−6.
- Hojris I., Sand N., Andersen J. et al. Myocardial perfusion imaging in breast cancer patients with or without post-mastectomy radiotherapy. // Radiother Oncol. 2000. — V.55. — P. 163−172.
- Hoppe R.T. Hodgkin’s disease: Complications of therapy and excess mortality. // Ann One. 1997. -V.8. — P. 115−118.
- Hudson M.M., Poquette C.A., Lee J. et al. Increased mortality after successful treatment for Hodgkin’s disease. // J Clin Oncol/ 1998. — V.16(l 1). — P.3592 600.
- Hurkmans C.W., Cho B.C. et al. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. // Radiother Oncol. 2002. — V.62(2) — P. 163−171.
- Ikaheimo MJ, Niemela КО, Linnaluoto MM, Jakobsson MJ, Takkunen JT, Taskinen PJ. Early cardiac changes related to radiation therapy. // Am. J. Cardiol. 1985. — V. 156(15). — P.943−946.
- Jahangiri M., Edmondson S.J., Rees G.M. Surgery for radiation-induced valvular disease. // J Heart Valve Dis. 1995. — V.4(3). — P.288−90.
- Jensen B.V., Skovsgaard Т., Nielsen S.L. Functional monitoring of anthracy-cline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients. //Ann Oncol. 2002. — V. l3(5). — P.699−709.
- Jeremic В., Jevremovic S., Djuric L., Mijatovic L. Cardiotoxicity during chemotherapy treatment with 5-fluorouracil and cisplatin. //J Chemother. 1990. — V.2(4). — P.264−7.
- Johansson A.S., Erlanson M., Lenner P., Lindh J., Osterman B. Late side-effects are common after treatment of Hodgkin’s disease. Muscular atrophy following radiotherapy is a neglected risk. Lakartidningen 1998 Jan 7−95(l-2):44−7
- Joyeux M, Godin-Ribuot D, Faure P et al. Heat stress protects againstrelectro-physiological damages induced by acute doxorubicin exposure in isolated rat hearts. // Cardiovasc Drugs Ther. -2001. V. l5(3). — P.219−24.
- Katz N.M., Hall A.W., Cerqueira M.D. Radiation induced valvulitis with late leaflet rupture. //Heart. 2001. — V.86(6). — P.20.
- Keefe D.L. Cardiovascular emergencies in the cancer patient. //Semin Oncol. — 2000. V.27(3). — P.244−55.
- Khan M.H., Ettinger S.M. Post mediastinal radiation coronary artery disease and its effects on arterial conduits. //Catheter Cardiovasc Interv. 2001. -V.52(2). — P.242−8.
- Khaw В. A., Gold H.K., Yasuda T. et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. //Circulation. 1986. — V.74. -P.501−508.
- Kirac F.S. Radiation and the heart. // Anadolu Kardiyol Derg. 2001. — V. 1(4).- P.276−82, AXVI.
- Kleikamp G., Schnepper U., Korfer R. Coronary artery and aortic valve disease as a long-term sequel of mediastinal and thoracic irradiation. // Thorac Cardio-vasc Surg. 1997. — V.45(l). — P.27−31.
- Knight C.J., Sutton G.C. Complete heart block and severe tricuspid regurgitation after radiotherapy. Case report and review of the literature. //Chest/ 1995. -V. 108(6).-P. 1748−51.
- Koontz B.F., Kirkpatrick J.P. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin’s disease: cure balanced against complications. //J Clin Oncol. 2006. — V. l-24(4). — P.544−8.
- Kotamraju S., Tampo Y., Keszler A., Chitambar C.R., et al. Nitric oxide inhibits H202-induced transferrin receptor-dependent apoptosis in endothelial cells:
- Role of ubiquitin-proteasome pathway. I I Proc Natl Acad Sci USA.- 2003. -V.16−100(19). P.10 653−8.
- Lacko A., Wlodarska I., Zymlinski R. et al. Cardiac toxicity in cancer therapy. //Pol Merkuriusz Lek. 2002. — V. 13(73). — P.79−85.
- Lahtinen R., Kuikka J., Nousiainen Т., et al. Cardiotoxity of epirubicin and doxorubicin: a double-blind randomized study. Eyr J Haematol. 1991. — V.46.- P.301−305.
- Larsen R.L., Jakacki R.I., Vetter V.L., Meadows A.T., Silber J.H., Barber G. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. // Am J Cardiol. 1992. — V. l-70(l). — P.73−7.
- Lauk S., Kiszel Z., Buschmann J., Trott K.R. Radiation-induced heart disease in rats. // Int J Radiat Oncol Biol Phys. 1985. — V. l 1(4). — P.801−8.
- Lenzhofer R., Dudczak R. Indication of doxorubicin cardiotoxicity by impairment of 131I-PIPP A utilization. //Eur JNucl Med. 1986.-V.12.-P.S32-S33.
- Leong A.S., Forbes I.J., Ruzic T. Radiation-related coronary artery disease in Hodgkin’s disease. //Aust N Z J Med. 1979. — V.9(4). — P.423−5.
- Lewitt S., Fletcher G. Trials and tribulations do clinical trials prove that irradiation increases. cardiac and secondary cancer mortality in the breast cancer patient? //J. Radiat. Oncol. Biol. Phys. 1991. -V.2. — P.523−527.
- Liao Z., Ha C.S., Vlachaki M.T., Hagemeister F. et al. Mantle irradiation alone for pathologic stage I and II Hodgkin’s disease: long-term follow-up and patterns of failure. //Int J Radiat Oncol Biol Phys/ 2001. — V. 15 -50(4). — P.971 -7.
- Linch D.C., Gosden R.G., Tulandi Т., Tan S.L., Hancock S.L. Hodgkin’s Lymphoma: Choice of Therapy and Late Complications. // Hematology Am. Soc. Hematol. Educ. Program. 2000. -P.:205−221.
- Ling L.H., Oh J.K., Schaff H.V. et al. Constrictive pericarditis I the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. // Circulation. 1999. — V.100 — P. 1380−1386.
- Lipshultz S.E., Colan S. Di, Gelber R.D., et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. //N Engl J Med. -1991. V.324. -P.808−815.
- Lipshultz S.E., Lipsitz S.R., Mone S.M. et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. //N Engl J Med. 1995. — V.332. — P. 1738−1743.
- Lipshultz S.E., Rifai N., Sallan S.E., Lipsitz S.R., et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. // Circulation. 1997. — V.96. — P.2496−2497.
- Lipshultz S.E., Sallan S.E. Cardiovascular abnormalities in long-term survivors of childhood malignancy. //J Clin Oncol. 1993. — V. l 1.- P. 1199−1203.
- Lipshultz S.E., Sanders S.P., Goonn A.M. et al. Monitoring for anthra-cycline cardiotoxicity. // Pediatrics. 1994. — V.93. — P.433−437.
- Loire R., Fareh S., Goineau P., Pinede L., Bizollon M.H. Post-radiotherapy pericarditis- a clinical and pathological study of 75 cases. //Arch Mai Coeur Vaiss 1996. V.89(l 1). — P.1357−62.
- Lones J.M., Ribeiro G.G. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy .//Clin Radiol. -'1989. -V.40. -P.204−208.
- Longo S., Cardim N., Mendonca C., Lousada N., et al. Heart disease induced by mediastinal radiotherapy in Hodgkin’s disease: report of a clinical case. //Rev Port Cardiol. 1997. — V. l6(7−8). — P.627−32.
- Massing J., Caillot D., Casasnovas R.O. et al. Early detection of anthracycline cardiotoxicity interest of radionuclide angiography analysis of left ventncular filling parameters. //Eur J Nucl Med. 1996. — V. 19. — P.667.
- Maunoury C., Pierga J-Y., Valette H. et al. Myocardial perfusion damage atfer mediastmal irradiation for Hodgkin’s disease a thallium-201 single photon emission tomography study. //Eur J Nucl Med. 1992. — V. l9. — P.871−873.
- McEniery P.T., Dorosti K., Schiavone W.A., Pedrick T.J., Sheldon W.C. Clinical and angiographic features of coronary artery disease after chest irradiation. //Am J Cardiol. 1987. — V. l-60(13). -P.1020−4.
- Mert M., Arat-Ozkan A., Ozkara A., AydemirN.A., Babalik E. Radiation-induced coronary artery disease. IIZ Kardiol. 2003. — V.92(8). — P.682−5.
- Minow R.A., Benjamin R.S., Lee E.T., Gottheb J.A. Adriamycin cardiomyopathy risk factors. // Cancer. 1977. -V.39. — P. 1397−1402.
- Mladosievicova В., Foltinova A., Luptak I., Petrasova H., Hulin I. Frequency-Domain Analysis of the QRS Complex After Treatment of Childhood Cancer with Anthracycline Cytostatics. // Pediatr. Cardiol. 2001. — V.22(6)., — P.478−482.
- Mordente A., Meussi E., Martorana G.E., Giardina B. et al. Human heart cyto-solic reductases and anthracycline cardiotoxicity.//IUBMB Life. 2001. -V.52(l-2). -P.83−8.
- Morgan G.W., Freeman A.P., McLean R.G. et al. Late cardiac, thyroid and pulmonary sequelae of mantle radiotherapy for Hodgkm’s disease. //Int. J. Ra-diat. Oncol. Biol. Phys. 1985. -V. 11. -P. 1925−1931.
- Mortensen S.A., Olsen H.S., Baandrup U. Chronic anthracycline cardiotoxity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease. // Br Heart J. 1986. — V.55. — P.274−282 .t
- Notaristefano S., Giombolini C.5 Santucci S., Fortunati F., et al. Radiation-induced ostial stenosis of the coronary artery as a cause of acute coronary syndromes: a novel mechanism of thrombus formation? //Ital Heart J. 2003. -V.4(5). — P.341−4.
- Nousiainen Т., Jantunen E., Vannienen E. et al. Natriuretic peptides as markers of cardiotoxity during doxorubicin treatment for non- Hodgkin’s lymphoma. // Eur J Hematol. 1999. — V.62. — P. 135−141.
- Nousiainen Т., Vanninen E., Jantunen E. et al. Anthracycline-induced'cardiomyopathy long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake. //Clin Physiol. -2001. -V.21. P. 123−128.
- Nousiainen Т., Vanninen E., Jantunen E., Remes J., et al. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients. //Clin Sci (Lond). 2001. — V. 101(6).1. P.601−7.
- Nutsu N., Yamazaki J., Nakayama M., Umeda M. Pirarabicin-induced myocardial damage in elderly patients with non-Hodgkin's lymphoma. //Nippon Ronen Igakkal Zasshi/ 1998. — V.35. — P.358−362 .
- Om A., Ellahham S., Vetrovec G.W. Radiation-induced coronary artery disease. //Am Heart J. 1992. — V. 124(6). — P. 1598−602.
- Orzan F., Brusca A., Conte M.R., Presbitero P., Figliomeni M.C. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. //Br Heart J. 1993. — V.69(6). — P.496−500.
- Orzan F., Brusca A., Gaita F., Giustetto C., Figliomeni M.C., et al. Associated, cardiac lesions in patients with radiation-induced complete heart block. //Int J Cardiol- 1993. V.39(2). -P.151−6.
- Parmentier S., Melin J.A., Piret L., Beckers C. Assessment of left ventncular diastolic function in patients receiving anthracycline therapy. //EurJNuclMed. — 1988. -V.13. P.563−567 .
- Perrault D.J., Levy M., Herman J. D, Burns R.J., et al. Echocardiographic abnormalities following cardiac radiation.// J. Clin. Oncol. 1985. — V.(4). -P.546−551.
- Pierga J-Y., Maunoury C., Valette H. et al. Follow-up thallium-201 scmtigra-phy after mantle field radiotherapy for Hodgkin’s disease. //Int J Radiat Oncol Biol Phys. 1993. — V.25. — P.871−876.
- Pihkala J., Saarinen U.M., Lundstrom U., et al. Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation. //Eur J Cancer. 1996. — V.32A (1). — P.97−103 .
- Pilliere R., Luquel L., Brun D., Jault F., Gandjbakhch I., Bourdarias J.P. Ostial stenosis of the left main coronary artery after mediastinal radiotherapy. Apropos of a case. //Arch Mai Coeur Vaiss. 1991. -V.84(6). — P.869−72.
- Piovaccari G., Ferretti R.M., Prati F., Traini A.M., Gobbi M., et al. Cardiac disease after chest irradiation for Hodgkin’s disease: incidence in 108 patients with long follow-up. // Int J Cardiol. 1995. — V.24−49(l). — P.39−43.
- Pohjola-Sintonen S., Totterman K.J., Salmo M., Siltanen P. Late cardiac effects of mediastinal radiotherapy in patients with, Hodgkin's disease. //Cancer. -1987. V. l-60(l). -P.31−7.
- Posner M.R., CohenG.I., Skarin A.T. Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis. // Am J Med. 1981. — V.71(3). — P.407−13.
- Putterman С., Polliack A. Late cardiovascular and pulmonary complications of therapy in Hodgkin’s disease: report of three unusual cases, with a review of relevant literature. // Leuk Lymphoma. 1992. — V.7(1 -2). — P. 109−15.
- Radwaner B.A., Geringer R., Goldmann A.M., Schwartz M.J., Kemp H.G. Jr. Left main coronary artery stenosis following mediastinal irradiation. // Am J Med. 1987.- V.82(5). — P. l017−20.
- Reber D., Birnbaum D.E., Tollenaere P. Heart diseases following mediastinal irradiation: surgical management. // Eur J Cardiothorac Surg. 1995. — V.9(4). — P.202−5.
- Reinders J.G., Heijmen B.J., Olofsen-van Acht M.J., van Putten W.L., er al. Ischemic heart disease after mantlefield irradiation for Hodgkin’s disease in long-term follow-up. // Radiother Oncol. 1999. — V.51(l). — P.35−42.
- Renner S.M., Massel D., Moon B.C. Mediastinal irradiation: A risk factor for atherosclerosis of the internal thoracic arteries. // Can J Cardiol. — 1999. —1. V. 15(5). P.597−600.
- Ricart Y., Petnz L., Prat L. et al. In-antimyosm myocardial scintigraphy in patients undergoing mediastinum or whole body irradiation. // EurJNuclMed. -1992.-V.19.- P.672.
- Rodgers D.L. Precocious myocardial infarction after radiation treatment for Hodgkin’s disease. // Chest. 1976. — V.70(5). — P.675−7.
- Rosenberg S.A. The continuing challenge of Hodgkin’s disease. //Ann. Oncol. -1991. -V.2. P.29−31.
- Rutqvist L.E., Lax I., Fornander Т., Johannson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. // Int J Radial Oncol Biol Phys. 1992. — V.22. — P.887−896.
- Sakuraba M., Tanaka J., Ikeda S., Kigawa I., Fukuda S., Wanibuchi Y. A case of post-radiation constrictive pericarditis developing 12 years after radiation therapy. // Nippon Kyobu Geka Gakkai Zasshi. 1997. — V.45(l 1). — P. 1893−7.
- Savage D.E., Constine L.S., Schwartz R.G., Rubm P. Radiation effects on left ventricular function and myocardial perfusion in long-term survivors of Hodgkm’s disease. //Int. J. Radiat. Oncol. Biol. Phys. 1990. — V.19. -P.721−727.
- Schoen F.J., Berger B.M., GuerinaN.G. Cardiac effects of noncardiac neoplasms. // Cardiol Clin. 1984. — V.2(4). — P.657−70.
- Schulman H.E., Korr K.S., Myers T.J. Left internal thoracic artery graft occlusion following mediastinal radiation therapy. // Chest. — 1994. V. l05(6). -P.1881−2.
- Schultz-Hector S., Kallfass E., Sund M. Radiation sequela in the large arteries. A review of clinical and experimental data // Strahlenther Onkol. 1995. -V.171(8). —P.427−36.
- Schwartz R.G., McKenzie W.B., Alexander J. et al. Congestive heart failure and left ventricular dysfunction-complicating doxorubicin therapy Seven-year experience using serial radionuclide angiocardiography. // Am J Med. 1987. -V.82.-P.1109−1118 .
- Seddon В, Cook A., Gothard L., Salmon E., Latus K., et al. Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. // Radiother Oncol. 2002. — V.64(l). — P.53−63.
- Shapiro C.L., Hardenbergh P.H., Gelman R. et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. // J Clin Oncol. -1998. V.16. — P.3493−3501.
- Shashaty G.G. Aortic insufficiency following mediastinal radiation for Hodgkin’s disease. // Am J Med Sci 1984. — V.287(l). — P.46−7.
- Sigal-Saglier M., Guillevin L., Tucat G., Godeau P. Cardiac localizations of lymphomas. A case report and review of the literature.// Sem Hop. 1980. -V.8−15−56(45−46). — P.1879−81.
- Simbre II V.C., Adams M.J., Deshpande S.S. et al. Cardiomyopathy Caused by Antineoplastic Therapies. // Curr Treat Options Cardiovasc Med. -2001'. V.3(6). — P.493−505.
- Steinberg J.S., Wasserman A.G. Radionuclide ventnculography for evaluation and prevention of doxorubicin cardiotoxicity. // Clin Ther. 1985. — V.7. — P. 660−667.
- Steinherz L.J., Steinherz P.J., Tan C.T. et al. Cardiac toxity 4 to 20 years after completing anthracycline therapy. // JAMA. 1991. -V.226. — PI 1672−1677.
- Stewart J.R., Fajardo L.F. Radiation-induced heart disease: an update. // Proge Cardiovasc Dis. 1984. — V.27. — P. 173−194.
- Stewart J.R., Fajardo L.F., Gillette S.M., Constine L.S. Radiation injury to the heart. // Int J Radiat Oncol Biol Phys. 1995. — V.30−31(5). — P.1205−1.
- Strashun A. Adnamycin, congestive cardiomyopathy, and meta-iodobenzylguanidine. // JNuclMedi 1992. — V.33. — P.215−222 .
- Suzuki J., Yanagisawa A., Shigeyama T. et al. Early detection of anthracycline-mduced cardiotoxicity by radionuclide angiocardio-graphy. //Angiology. — 1999. V.50.- P.37−45.
- Suzuki M., Hamada M., Matsumoto Y., Hiwada K., Osuka Y. Aortic valvular disease and right coronary artery stenosis induced by mediastinal irradiation-report of a case. // Jpn Circ J. 1993. — V.57(5). — P.467−71.
- Takahashi S., Maida K., Yokoyama H., Tanaka S. Heart failure due to severe myocardial calcification—a rare complication after irradiation on the chest wall. //Nippon Kyobu Geka Gakkai Zasshi. 1993. — V.41(11). — P.2206−9.
- Tarbell N.J., Thompson L., Mauch P. Thoracic irradiation in Hodgkin’s didease: disease control and long-term complications. // Int J Radiat Oncol Biol Phys. 1990. — V. 18(2). — P.275−81.
- Tassinari d., Sartori S., Drudi G et al. Cardiac arrhythmias after cisplatin in fusion: Three case reports and review of the literature. // Ann. of One. 1997. — V.8. — P.1263−1267.
- Totterman K.J., Pesonen E., Siltanen P. Radiation-related chronic heart disease. //Chest. 1983. — V.83(6). — P.875−878.
- Travis L.B. Evaluation of the risk of therapy-associated complications in survivors of hodgkin lymphoma. //Hematology Am. Soc. Hematol. Educ. Program. -2007. -V.2007.- P. 192−196.
- Vacheron A., Heulin A., Metzger J.P., Baubion N., Le Pailleur C., Delage F., Gilles R., Laugier A., Schlienger M., Delaby F. Cardiac complications of radiotherapy. //Ann Cardiol Angeiol (Paris). 1983. — V.32(7). — P.465−72.
- Valagussa P., Zambetti M., Biasi S. et al. Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer. //Ann Oncol. -1994. -V.5. -P.209−216.
- Valdes Olmos R.A., Bokkel Hummk W.W.ten Hoeve R.F. et al. Assessment ofanthracyclme-related myocardial adrenergic derangement by 1231. metaio-dobenzylguanidme scintigraphy.//Eur. J. Cancer. — 1995. V.31A. -P.26−31.
- Valdes Olmos R.A., Bokkel Hummk W.W. ten Hoeve R.F. et al. Usefulnesstof indium-Ill antimyosm scintigraphy in confirming myocardial injury in patients with anthracycline-associated left1 ventncular dysfunction. //Ann Oncol. -1994.-V.5.-P.617−622.
- Valdes Olmos R.A., ten Bokkel Hummk W.W., Dewit L.G. et al. Iodine-123 metaiodobenzy lguanidine in the assessment of late cardiac effects from cancer therapy. // Eur. J. Nucl. Med. 1996. — V.23. — P. 453−458.
- Valdes Olmos R.A., Bokkel Humink W.W., Greve J., Hoefnagel C.A. 1−123 MIBG and senal radionuclide angiocardiography in doxo-rubicm-related cardiotoxicity. // Clin Nucl Med. 1992. — V. 17. — P. 163−167.
- Valdes Olmos R.A., Hoefnagel C.A., van der Schoot J.B. Nuclear medicine infthe monitoring of organ function and the detection of injury related to cancer therapy. //Eur. J. Nucl. Med. 1993. — V.20. -P.515−546.
- Vallebona A. Cardiac damage following>therapeutic chest irradiation. Importance, evaluation and treatment. // Minerva Cardioangiol. 2000. — V.48(3). -P.79−87.
- Vallis K.A., Pintilie M., Chong N., Holowaty E., Douglas P. S., Kirkbride P., Wielgosz A. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. // J’Clin Oncol. 2002. — V.15−20(4). -P. 1036−42.
- Veeragandham R.S., Goldin M.D. Surgical management of radiation-induced heart disease. // Ann Thorac Surg 1998. — V.65(4). — P. 1014−9.
- Veinot J.P., Edwards W.D. Pathology of radiation-induced heart disease: a surgical and. autopsy study of 27 cases. // Hum Pathol/ 1996 — V.27(8).- P.766−73.
- Virmani R., Farb A., Carter A.J., Jones R.M. Comparative pathology: radiation-induced coronary artery disease in man and animals. // Semin Interv Cardiol. — 1998.-V.3(3−4).-P. 163−72.
- Virmani R., Farb A., Carter A.J., Jones R.M. Pathology of radiation-induced coronary artery disease in human and pig. // Cardiovasc Radiat Med. 1999. -V.l (l). — P.98−101.
- Vlachaki M., Ha C., Hagemeister F. et al. Stage I Hodgkin disease radiation therapy and chemotherapy at the University of Texas M D Anderson Cancer Center. 1967−1977.//Radiology 1998. — V.208.-P.739−747.
- Von Hoff D.D., Layard M.W., Basa P. et al. Risk factors for doxorubicin-induced congestive heart falure. //Ann Intern Med. 1979. — V.91. — P.710−717.
- Weinstein P., Greenwald E.S., Grossman J. Unusual cardiac reaction to chemotherapy following mediastinal irradiation in a patient with Hodgkin’s disease. // Am J Med. 1976. — V.60(l). — P.152−6.
- Wondergem J., Franken N.A., van der Laarse A., et al. Changes in cardiac performance and sympathetic stimulation during and after fractionated radiotherapy in a rat model. // Radiother Oncol. 1996. — V.8(l). — P.33−40.
- Wondergem J., Strootman E.G., Frolich M., Leer J.W., Noordijk E.M. Circulating atrial natriuretic peptide plasma levels as a marker for cardiac damage after radiotherapy //Radiother Oncol. 2001. — V.58(3). — P.295−301.
- Young R.C., Bookman M.A., Longo D.L. Late complications of Hodgkin’s disease management //J Natl Cancer Inst Monogr. -1990. V. 10. — P.55−60.
- Zietman AL, Suit HD, Okunieff PG, Donnelly SM, Dieman S, Webster S. The life shortening effects of treatment with doxorubicin and/or local irradiation on a cohort of young C3Hf/Sed mice // Eur. J. Cancer 1991. — V.7(6). — P.778−781.